SEC Form D · Amendment · filed January 4, 2023
MINERVA BIOTECHNOLOGIES Corp
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Ronald R. Axelrod · Waltham, MADirectorRobert Staszewski · Waltham, MADirectorKenneth Kosik · Waltham, MADirectorLawrence A. Coolidge · Waltham, MADirectorJames R. Bridges · Waltham, MADirectorJoseph A. Nathan · Waltham, MADirectorCynthia Bamdad · Waltham, MAExec · DirectorKenneth A. Reed · Waltham, MADirectorLowell J. Burnett · San Diego, CADirectorBrandon Jundt · Denver, COExec · DirectorTaylor Hobbs · Waco, TXDirectorJames V. O'Donnell · Saint Louis, MODirectorSharon C. Geraghty · Winnepeg, Manitoba, CanadaDirectorBrent Eley · Bellevue, WADirectorMilton Pinsky · Northbrook, ILExec · DirectorBrad Sargent · Cupertino, CADirectorMichael Cassara · San Diego, CADirectorBenjamin Alfonsi · New York, NYDirectorMichael Skead · Vancouver, British Columbia, CanadaDirectorFrank C. Foster · Santa Barbara, CADirectorAndrew Rosen · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗